SurModics
SRDX
#6828
Rank
โ‚ฌ0.52 B
Marketcap
36,91ย โ‚ฌ
Share price
0.00%
Change (1 day)
-2.50%
Change (1 year)
Categories

Revenue for SurModics (SRDX)

Revenue in 2025 (TTM): โ‚ฌ0.10 Billion

According to SurModics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.10 Billion. In 2024 the company made a revenue of โ‚ฌ0.12 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SurModics from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.10 B-9.06%
2024 โ‚ฌ0.12 B-3.57%
2023 โ‚ฌ0.12 B31.63%
2022 โ‚ฌ94.97 M1.63%
2021 โ‚ฌ93.45 M21.59%
2020 โ‚ฌ76.86 M-14.28%
2019 โ‚ฌ89.67 M18.51%
2018 โ‚ฌ75.66 M25.46%
2017 โ‚ฌ60.31 M-12.6%
2016 โ‚ฌ69 M17.47%
2015 โ‚ฌ58.74 M23.69%
2014 โ‚ฌ47.49 M16.78%
2013 โ‚ฌ40.66 M-0.13%
2012 โ‚ฌ40.71 M-4.55%
2011 โ‚ฌ42.66 M-12.75%
2010 โ‚ฌ48.89 M-7.46%
2009 โ‚ฌ52.83 M-45.86%
2008 โ‚ฌ97.59 M77.57%
2007 โ‚ฌ54.96 M3.37%
2006 โ‚ฌ53.17 M-2.77%
2005 โ‚ฌ54.68 M43.42%
2004 โ‚ฌ38.12 M1.55%
2003 โ‚ฌ37.54 M24.69%
2002 โ‚ฌ30.11 M10.62%
2001 โ‚ฌ27.22 M35.24%
2000 โ‚ฌ20.12 M35.09%
1999 โ‚ฌ14.89 M68.39%
1998 โ‚ฌ8.84 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nektar Therapeutics
NKTR
โ‚ฌ53.76 M-48.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ37.55 B 36,104.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚ฌ23.59 M-77.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚ฌ1.30 B 1,159.38%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
โ‚ฌ79.13 B 76,181.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ37.65 B 36,193.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Agilent Technologies
A
โ‚ฌ5.82 B 5,519.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
โ‚ฌ0.13 B 28.39%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚ฌ2.88 B 2,679.32%๐Ÿ‡บ๐Ÿ‡ธ USA